Press Release

  • Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

  • Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch PTA Sirolimus Coated Balloon, for the treatment of Peripheral Artery Disease (PAD) in Below-the -knee (BTK) indication

  • Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From FDA for Its MagicTouch Sirolimus Coated Balloon

  • Concept Medical has created a niche for itself with its innovative drug-coated stent and balloon catheter for diabetic heart patients

  • Economics Times Rising Indians 2019

  • Concept Medical Inc. Raises $60mn for Investigational Device Exemption (IDE) for the World's First Sirolimus-Coated Balloon